|
|
§ 63-10-201 |
Short title |
§ 63-10-202 |
Practice of pharmacy |
§ 63-10-203 |
Statement of purpose |
§ 63-10-204 |
Definitions |
§ 63-10-205 |
Consultation on drugs by board to department of health |
§ 63-10-206 |
Sale of nonprescription drugs and devices |
§ 63-10-207 |
Dispensing of medication prior to authorization |
§ 63-10-208 |
Penalty for violation |
§ 63-10-209 |
Distribution of drugs or drug samples by manufacturer’s representative – Distribution of free samples |
§ 63-10-210 |
Registration fees for out-of-state pharmacies mailing into Tennessee |
§ 63-10-211 |
Consortia for bulk purchases authorized |
§ 63-10-212 |
Confidentiality of information entrusted to pharmacist |
§ 63-10-213 |
Legibility of prescriptions |
§ 63-10-214 |
Centralized prescription processing – Licensing – Rules |
§ 63-10-215 |
Transfer of prescriptions to another prescription form |
§ 63-10-216 |
Compounding pharmacies |
§ 63-10-217 |
Collaborative pharmacy practice agreements |
§ 63-10-218 |
Professional judgment in dispensing of varying quantities of medication not to exceed ninety-day supply – Exclusion of controlled substances |
§ 63-10-219 |
Provision of hormonal contraceptives |
§ 63-10-220 |
Facilities engaging in distribution of dialysate and devices for home use |
§ 63-10-221 |
Medication therapy management – Standards |
§ 63-10-222 |
Medication therapy management pilot program – Reporting of costs and patient outcomes |
§ 63-10-223 |
Agreement limiting ability of pharmacist to discuss issue related to dispensing of controlled substance with patient void and unenforceable |
§ 63-10-224 |
Provision of ivermectin by pharmacists |